dab color developer (OriGene)
OriGene is a verified supplier 
OriGene manufactures this product 
94
Structured Review
OriGene
dab color developer
Dab Color Developer, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dab+color+development+kit/Klear+Human+HRP-Polymer+with+DAB+Bulk+Kit/pmc13157100-44-1-7
Average 94 stars, based on 11 article reviews
Dab Color Developer, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dab+color+development+kit/Klear+Human+HRP-Polymer+with+DAB+Bulk+Kit/pmc13157100-44-1-7
Average 94 stars, based on 11 article reviews
dab color developer - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
DNA Extraction:Article Title: Autism-Associated Gut Microbiota–Derived Enterococcus facium Modulates Gut–Brain Axis Function and Behavior in Mice Article Snippet: ELISA kits for mouse IL-6, IL-10, 5-HT, and LPS were obtained from Jianglai Biological. .. The Negative Control:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Over Expression:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Plasmid Preparation:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. CCK-8 Assay:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. TUNEL Assay:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. In Situ:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Extraction:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Isolation:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Transfection:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Luciferase:Article Title: Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway. Article Snippet: Objective: Pancreatic cancer is one of the most aggressive malignant tumors in humans, with poor prognosis.. The acetylase tumor inhibitor (Pracinostat) has been shown to suppress the growth of various tumors.. This study aimed to investigate the effects of Pracinostat on the pancreatic cancer cell line BxPC3 and to explore the underlying molecular mechanisms through both in vivo and in vitro experiments. Incubation:Article Title: A novel circular RNA circ_0020647 promotes ETEC-induced IPEC-J2 cell pyroptosis via the ssc-miR-185/BRD4 axis Article Snippet: .. After primary antibody incubation at 4°C overnight, the membrane was incubated with a secondary antibody at room temperature for 1.5 h and proceeded with a Membrane:Article Title: A novel circular RNA circ_0020647 promotes ETEC-induced IPEC-J2 cell pyroptosis via the ssc-miR-185/BRD4 axis Article Snippet: .. After primary antibody incubation at 4°C overnight, the membrane was incubated with a secondary antibody at room temperature for 1.5 h and proceeded with a other:Article Title: Conditioned medium of engineering macrophages combined with soluble microneedles promote diabetic wound healing. Article Snippet: This technique was employed to visualize |